Welcome to PsychU!

Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

This is a Virtual Event for PsychU members in DC, Maryland, North Carolina, South Carolina, and Virginia.

This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD.

Featuring

Chris-Brodie

Chris Brodie, PhD (OPDC)

Medical Science Liaison

Justin-Wimmer

Justin Wimmer, PharmD (OPDC)

Medical Science Liaison

Speakers Chris Brodie, PhD and Justin Wimmer, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Log in to register

Related Resources

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Join PsychU Today to receive a wide array of tools and benefits

  • Join our multidisciplinary community that is improving mental health care… together
  • Quickly learn more about the topics you're interested in
  • Access an award-winning library of on-demand mental health resources
  • Gain key insights from industry expert & thought leaders